Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody

Kou, JQ; Musich, PR; Staal, B; Kang, L; Qin, Y; Yao, ZQ; Zhang, BH; Wu, WZ; Tam, A; Huang, A; Hao, HX; Vande Woude, GF; Xie, Q

Xie, Q (reprint author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.

JOURNAL OF TRANSLATIONAL MEDICINE, 2018; 16 ():

Abstract

Background: Aberrant MET tyrosine kinase signaling is known to cause cancer initiation and progression. While MET inhibitors are in clinical trials ag......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索